Standard Biotools (LAB) EBITDA Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 50.00 |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 519.00 |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 293.00 |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 93.00 |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -36.00 |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 3,065.00 |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | -68.00 |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -77.00 |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -3,037.00 |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn | -820.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -820.00 |
| Mar 31, 2026 | 7,428.00 |
| Dec 31, 2025 | 170.00 |
| Sep 30, 2025 | -4,758.00 |
| Jun 30, 2025 | 1,646.00 |
| Mar 31, 2025 | -122.00 |
| Dec 31, 2024 | -2,940.00 |
| Sep 30, 2024 | -3,742.00 |
| Jun 30, 2024 | -7,147.00 |
| Mar 31, 2024 | -6,609.00 |
| Dec 31, 2023 | 226.00 |
| Sep 30, 2023 | 2,972.00 |
| Jun 30, 2023 | 14,230.00 |
| Mar 31, 2023 | 3,771.00 |
| Sep 30, 2022 | -5,231.00 |
| Jun 30, 2022 | -14,804.00 |
| Mar 31, 2022 | -4,486.00 |
| Sep 30, 2021 | -4,717.00 |
| Jun 30, 2021 | -466.00 |
| Mar 31, 2021 | -481.00 |